Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1132 | 1026 | 1210 | 1096 | 1233 | 1375 |
Fund Return | 13.18% | 2.58% | 20.98% | 3.11% | 4.28% | 3.23% |
Place in category | 334 | 718 | 529 | 524 | 749 | 485 |
% in Category | 11 | 24 | 17 | 21 | 36 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bellevues Lux BB Adamant Medtech HB | 1.58B | 8.29 | -4.05 | 7.91 | ||
Adamant Medtech B EUR | 1.58B | 11.11 | 0.30 | 11.14 | ||
Adamant Medtech I EUR | 1.58B | 11.77 | 1.01 | 11.93 | ||
Adamant Medtech T EUR | 1.58B | 11.49 | 0.70 | 11.58 | ||
LU1477743386 | 381.67M | 5.31 | -2.53 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Flossbach von Storch S Multiple Opf | 25.08B | 9.40 | 2.57 | 6.81 | ||
Flossbach von Storch S Multiple Opi | 25.08B | 8.65 | 2.56 | 6.33 | ||
Flossbach von Storch S Multiple Ope | 25.08B | 8.03 | 1.86 | 5.67 | ||
LU1663838545 | 14.53B | 5.06 | 2.92 | - | ||
Flossbach von Storch Multiple Oppoi | 11.45B | 7.93 | 2.01 | 6.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SPDR S&P 500 UCITS | IE00B6YX5C33 | 16.32 | 476.33 | +0.99% | |
Xtrackers MSCI USA UCITS ETF 1C | IE00BJ0KDR00 | 7.02 | 167.14 | +1.14% | |
Xtrackers MSCI Emerging Markets UCITS | IE00BTJRMP35 | 6.22 | 54.796 | +0.85% | |
Xtrackers MSCI Japan UCITS 1C | LU0274209740 | 3.51 | 6,332.5 | +1.05% | |
Italy (Republic Of) 0% | IT0005567778 | 2.92 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review